Valve replacement/repair | |||
---|---|---|---|
Mechanical valve replacement | Biological valve replacement (surgical) | Mitral valve repair (surgical) | |
• Baseline (4–6 weeks post operatively) • If baseline TTE normal and no alerts (see below), no routine surveillance • If regurgitation review by native valve criteria; consider TOE | • Baseline (4–6 weeks post operatively) • MV/TV or AV < 60 years (unless alerts, see below): Annual TTE from 5 years post implant (for new valve with no durability data annual from implantation) • AV > 60 years and AV with proven longevity: Annual surveillance TTE from 10 years post implant (unless alerts, see below) If regurgitation review by native valve criteria | • Competent: Baseline (4–6 weeks post operatively), 1 year post op, then every 2–3 years • Incompetent: Individualised plan | |
Alerts for TTE/ Cardiologist review: • New or worsening prosthetic valve regurgitation • Gradient/effective orifice area outside of expected parameters • New LV dilatation or LV systolic dysfunction • Aortic root dilatation. Urgent if ≥ 45 mm in Marfan syndrome; ≥ 50 mm in bicuspid aortic valve; ≥ 55 mm for all other patients • Suggestion of infective endocarditis or previously medically treated prosthetic valve endocarditis • Worsening symptoms or other sonographer concerns | |||
Aortic valve and aortic root replacement | Aortic root surveillance post bicuspid aortic valve surgery | ||
• Ongoing assessment of the aortic root: individualised plan based on clinical, anatomical and surgical features • Reasonable default: 2 yearly cross sectional imaging | • If normal diameter by TTE, then TTE every 3–5 years • If aortic dilatation: individualised plan based on degree of dilatation and rate of progression on sequential TTE • If dilatation on TTE not reproducible with cCT/cMRI (> 2 mm difference): interval imaging with cCT or MRI | ||
TAVI | Mitral valve repair (transcatheter) | ||
• Baseline (4–6 weeks post operatively) or as directed by operator, then annular surveillance. If stable then increase TTE surveillance to 2 years • If paravalvular/transvalvular regurgitation review by native valve criteria • If other native valve stenosis/regurgitation, review by native valve criteria • Complex cases with LV dysfunction or multi-native valve disease: individualised plan | • Competent: Baseline (4–6 weeks post operatively), then annually • Incompetent: individualised plan |